SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021068
Filing Date
2022-08-04
Accepted
2022-08-04 16:10:04
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-20220630.htm   iXBRL 10-Q 1257136
2 EX-31.1 arwr-20220630xexx311.htm EX-31.1 9835
3 EX-31.2 arwr-20220630xexx312.htm EX-31.2 9833
4 EX-32.1 arwr-20220630xexx321.htm EX-32.1 4387
5 EX-32.2 arwr-20220630xexx322.htm EX-32.2 3981
  Complete submission text file 0001628280-22-021068.txt   6026627

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arwr-20220630.xsd EX-101.SCH 49826
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arwr-20220630_cal.xml EX-101.CAL 67967
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arwr-20220630_def.xml EX-101.DEF 242513
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arwr-20220630_lab.xml EX-101.LAB 557972
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arwr-20220630_pre.xml EX-101.PRE 386789
56 EXTRACTED XBRL INSTANCE DOCUMENT arwr-20220630_htm.xml XML 875312
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 221136616
SIC: 2834 Pharmaceutical Preparations